Queens Hospital Center, Jamaica
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Stony Brook University Medical Center, Stony Brook

피험자 모집 중관찰 연구건강한 지원자 환영

40세 ~ 75세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05334069

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

Mount Sinai Hospital, New York
University of Rochester, Rochester
Wilmot Cancer Institute at Webster, Webster

피험자 모집 중3상

65세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07321652

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

Research Site, New York

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT06564038

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

New York Medical College, Valhalla

피험자 모집 중1/2상

13세 ~ 90세 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06533579

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

Memorial Sloan Kettering Cancer Center Mskcc, New York
Optum Medical Care, Pc, Westbury

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT06943872

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

David H. Koch Center for Cancer Care, New York
Montefiore Medical Center PRIME, The Bronx

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 14. 업데이트됨 · NCT07648264

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

New York Oncology Hematology, P.C. ( Site 0069), Albany
Roswell Park Cancer Institute ( Site 0023), Buffalo
RPCI Oncology, PC- Northtowns ( Site 0061), Williamsville

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT06136559

Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia

NYP/Weill Cornell Medical Center, New York

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 10. 6. 업데이트됨 · NCT07061951

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Roswell Park Comprehensive Cancer Center, Buffalo
Columbia University Medical Center, New York
Weill Cornell Medical College Newyork Presbyterian Hospital, New York
외 1개

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT05006716

Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype

Roswell Park Cancer Institute, Buffalo

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06863402

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Research Site, New York
Research Site, New York

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT06542250

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

Columbia University Medical Center, New York

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07277231

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Columbia University Medical Center, New York
Weill Cornell Medical College Newyork Presbyterian Hospital, New York
Memorial Sloan Kettering Cancer Center Mskcc, New York
외 1개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT06973187

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

Columbia University Irving Medical Center/New York Presbyterian Hospital, New York

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT03666000

Zanubrutinib, Obinutuzumab, Sonrotoclax (BOSon) or BGB-16673, Obinutuzumab, Sonrotoclax (DOSon) in TN CLL/SLL

Memorial Sloan Kettering Cancer Center, New York

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT06849713

Impact of Targeted Therapy on Cancer-Related Cognitive Impairment

University of Rochester NCORP Research Base, Rochester

피험자 모집 중관찰 연구건강한 지원자 환영

18세 이상 · 모든 성별 · 2026. 6. 10. 업데이트됨 · NCT07638007

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Icahn School of Medicine at Mount Sinai /ID# 266328, New York

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 4. 9. 업데이트됨 · NCT06428019

Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial

Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 3. 13. 업데이트됨 · NCT07218510

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

Cayuga Cancer Center, Ithaca
Northwell Health, Lake Success
Memorial Sloan-Kettering Cancer Center (MSKCC) - New York, New York
외 2개

피험자 모집 중4상

18세 이상 · 모든 성별 · 2026. 3. 2. 업데이트됨 · NCT06876649

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Northwell Health, Lake Success
Memorial Sloan-Kettering Cancer Center (MSKCC) - New York, New York

피험자 모집 중4상

18세 이상 · 모든 성별 · 2026. 3. 2. 업데이트됨 · NCT06876662

Study of SGR-1505 in Mature B-Cell Neoplasms

Roswell Park Comprehensive Cancer Center, Buffalo
Weill Cornell, New York
Montefiore Medical Center, The Bronx

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 2. 13. 업데이트됨 · NCT05544019

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

Optum Medical Care PC, Westbury

피험자 모집 중1상

18세 이상 · 모든 성별 · 2025. 12. 10. 업데이트됨 · NCT05602363

Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors

Northwell (Northshore University/Long Island Jewish Hospitals), New Hyde Park

피험자 모집 중

18세 이상 · 모든 성별 · 2025. 9. 18. 업데이트됨 · NCT05643235

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.